Literature DB >> 25829498

Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.

Alexej Dick1, Laura Graf2, Daniel Olal3, Alexander von der Malsburg4, Song Gao5, Georg Kochs6, Oliver Daumke7.   

Abstract

Myxovirus resistance (Mx) GTPases are induced by interferon and inhibit multiple viruses, including influenza and human immunodeficiency viruses. They have the characteristic domain architecture of dynamin-related proteins with an N-terminal GTPase (G) domain, a bundle signaling element, and a C-terminal stalk responsible for self-assembly and effector functions. Human MxA (also called MX1) is expressed in the cytoplasm and is partly associated with membranes of the smooth endoplasmic reticulum. It shows a protein concentration-dependent increase in GTPase activity, indicating regulation of GTP hydrolysis via G domain dimerization. Here, we characterized a panel of G domain mutants in MxA to clarify the role of GTP binding and the importance of the G domain interface for the catalytic and antiviral function of MxA. Residues in the catalytic center of MxA and the nucleotide itself were essential for G domain dimerization and catalytic activation. In pulldown experiments, MxA recognized Thogoto virus nucleocapsid proteins independently of nucleotide binding. However, both nucleotide binding and hydrolysis were required for the antiviral activity against Thogoto, influenza, and La Crosse viruses. We further demonstrate that GTP binding facilitates formation of stable MxA assemblies associated with endoplasmic reticulum membranes, whereas nucleotide hydrolysis promotes dynamic redistribution of MxA from cellular membranes to viral targets. Our study highlights the role of nucleotide binding and hydrolysis for the intracellular dynamics of MxA during its antiviral action.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein; Mx proteins; antiviral response; catalytic mechanism; dynamin-like protein; innate immunity; interferon; membrane; viral replication

Mesh:

Substances:

Year:  2015        PMID: 25829498      PMCID: PMC4432294          DOI: 10.1074/jbc.M115.650325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

3.  Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers.

Authors:  Georg Kochs; Markus Haener; Ueli Aebi; Otto Haller
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

4.  Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.

Authors:  E Gordien; O Rosmorduc; C Peltekian; F Garreau; C Bréchot; D Kremsdorf
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 5.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

6.  A dynamin mutant defines a superconstricted prefission state.

Authors:  Anna C Sundborger; Shunming Fang; Jürgen A Heymann; Pampa Ray; Joshua S Chappie; Jenny E Hinshaw
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

7.  Inhibition of a large double-stranded DNA virus by MxA protein.

Authors:  Christopher L Netherton; Jennifer Simpson; Otto Haller; Thomas E Wileman; Haru-Hisa Takamatsu; Paul Monaghan; Geraldine Taylor
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

8.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

9.  Detection of new biallelic polymorphisms in the human MxA gene.

Authors:  Tam Tran Thi Duc; Frédéric Farnir; Charles Michaux; Daniel Desmecht; Anne Cornet
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

10.  Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.

Authors:  Patrick S Mitchell; Corinna Patzina; Michael Emerman; Otto Haller; Harmit S Malik; Georg Kochs
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

View more
  30 in total

1.  Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Authors:  Mirjam Schilling; Lorenzo Bulli; Sebastian Weigang; Laura Graf; Sebastian Naumann; Corinna Patzina; Valentina Wagner; Liane Bauersfeld; Caroline Goujon; Hartmut Hengel; Anne Halenius; Zsolt Ruzsics; Torsten Schaller; Georg Kochs
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

2.  Structural and functional characterization of the dominant negative P-loop lysine mutation in the dynamin superfamily protein Vps1.

Authors:  Bryan A Tornabene; Natalia V Varlakhanova; Christopher J Hosford; Joshua S Chappie; Marijn G J Ford
Journal:  Protein Sci       Date:  2020-01-31       Impact factor: 6.725

Review 3.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

4.  GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.

Authors:  Linlin Xie; Zhao Ju; Chaojie Zhong; Yingjun Wu; Yuxing Zan; Wei Hou; Yong Feng
Journal:  Virol Sin       Date:  2020-07-06       Impact factor: 4.327

5.  Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.

Authors:  Judith Verhelst; Jan Spitaels; Cindy Nürnberger; Dorien De Vlieger; Tine Ysenbaert; Peter Staeheli; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

6.  Evolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus Restriction.

Authors:  Patrick S Mitchell; Janet M Young; Michael Emerman; Harmit S Malik
Journal:  PLoS Pathog       Date:  2015-12-10       Impact factor: 6.823

7.  Human Antiviral Protein MxA Forms Novel Metastable Membraneless Cytoplasmic Condensates Exhibiting Rapid Reversible Tonicity-Driven Phase Transitions.

Authors:  Deodate Davis; Huijuan Yuan; Feng-Xia Liang; Yang-Ming Yang; Jenna Westley; Chris Petzold; Kristen Dancel-Manning; Yan Deng; Joseph Sall; Pravin B Sehgal
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

8.  Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.

Authors:  Jonas Fuchs; Martin Hölzer; Mirjam Schilling; Corinna Patzina; Andreas Schoen; Thomas Hoenen; Gert Zimmer; Manja Marz; Friedemann Weber; Marcel A Müller; Georg Kochs
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

9.  Influenza Virus Susceptibility of Wild-Derived CAST/EiJ Mice Results from Two Amino Acid Changes in the MX1 Restriction Factor.

Authors:  Cindy Nürnberger; Vanessa Zimmermann; Melanie Gerhardt; Peter Staeheli
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity.

Authors:  Laura Graf; Alexej Dick; Franziska Sendker; Emanuel Barth; Manja Marz; Oliver Daumke; Georg Kochs
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.